Elixophylline Related Published Studies
Well-designed clinical trials related to Elixophylline (Theophylline)
A randomized controlled trial of theophylline versus CO2 inhalation for treating apnea of prematurity. [2008.10]
A Randomized Controlled Trial of Theophylline Versus CO(2) Inhalation for Treating Apnea of Prematurity. [2008.06.03]
Effect of theophylline on endogenous hydrogen sulfide production in patients with COPD. [2008]
Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma--results from the ALA-ACRC low-dose theophylline trial. [2007.10]
The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. [2007.09]
In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets. [2007.08.16]
Theophylline improves esophageal chest pain--a randomized, placebo-controlled study. [2007.05]
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study. [2007.05]
Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline. [2007]
Theophylline does not potentiate the effects of a low dose of dexamethasone in horses with recurrent airway obstruction. [2006.11]
Effects of Salmeterol in Patients with Persistent Asthma Receiving Inhaled Corticosteroid plus Theophylline. [2006.09.05]
[Theophylline in the treatment of chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study] [2006.09]
A randomized open-label comparative study of montelukast versus theophylline added to inhaled corticosteroid in asthmatic children. [2006.09]
Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline. [2006.09]
Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year. [2006.09]
Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial. [2006.08]
Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study. [2006.06]
Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine. [2006.05]
A randomised, double blind, placebo controlled trial of the effect of theophylline in prevention of vasomotor nephropathy in very preterm neonates with respiratory distress syndrome. [2006.03]
Effects of theophylline on pulmonary function in patients with traumatic tetraplegia. [2006]
Theophylline as 'add-on' therapy to cetirizine in patients with chronic idiopathic urticaria. A randomized, double-blind, placebo-controlled pilot study. [2006]
Plant-based formulation for bronchial asthma: a controlled clinical trial to compare its efficacy with oral salbutamol and theophylline. [2006]
[Clinical and functional benefits of adding theophylline to a standard treatment with short acting bronchodilators in patients with COPD] [2005.10]
Efficacy and safety of intravenous theophylline administration for treatment of mild acute exacerbation of bronchial asthma. [2005.09]
Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia--a study in a developing country. [2005.09]
Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids. [2005.07]
[Changes of leukotriene B4 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and the effects of theophylline] [2005.07]
Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. [2005.05.23]
Short-term effects of oral theophylline in addition to CPAP in mild to moderate OSAS. [2005.04]
Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma. [2005.03]
Theophylline versus terbutaline in treating critically ill children with status asthmaticus: a prospective, randomized, controlled trial. [2005.03]
Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial. [2005.02]
Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine. [2005.01]
Pharmacokinetics of theophylline after administration of suppositories formulation. [2005]
A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease. [2005]
Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthma. [2005]
Well-designed clinical trials possibly related to Elixophylline (Theophylline)
The effects of aminophylline on bispectral index during inhalational and total intravenous anaesthesia. [2008.06]
Effects of endolymphatic sac drainage with steroids for intractable Meniere's disease: a long-term follow-up and randomized controlled study. [2008.05]
Impact of quality circles for improvement of asthma care: results of a randomized controlled trial. [2008.04]
Sleep quality in asthma: results of a large prospective clinical trial. [2008.04]
Cyclooxygenase products sensitize muscle mechanoreceptors in humans with heart failure. [2008.04]
Dimenhydrinate effect on cerebral oxygen status and salivary chromogranin-A during cognitive tasks. [2008.01.01]
Early administration of two intravenous bolus of aminophylline added to the standard treatment of children with acute asthma. [2008.01]
Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing. [2008]
In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine. [2008]
A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders : a randomized, reference-controlled clinical study. [2008]
Prevention of exercise-induced asthma by a fixed combination of disodium cromoglycate plus reproterol compared with montelukast in young patients. [2008]
Treatment of vertebrobasilar insufficiency--associated vertigo with a fixed combination of cinnarizine and dimenhydrinate. [2008]
Impact of quality circles for improvement of asthma care: results of a randomized controlled trial. [2007.12.13]
The effect of aminophylline on renal colic: a randomized double blind controlled trial. [2007.11]
A randomized comparison of ginger and dimenhydrinate in the treatment of nausea and vomiting in pregnancy. [2007.09]
Vestibular rehabilitation exercises in acute vertigo. [2007.08]
Prevention of contrast-induced nephropathy: a critical review. [2007.07]
High dose ondansetron for reducing motion sickness in highly susceptible subjects. [2007.07]
Effect of dimenhydrinate on autonomic activity in humans. [2007.06]
[Preoperative administration of angiotensin-converting enzyme inhibitors] [2007.06]
Acute action of aminophylline in patients with amyotrophic lateral sclerosis. [2007.05]
Pretreatment with aminophylline reduces release of Troponin I and neutrophil activation in the myocardium of patients undergoing cardioplegic arrest. [2007.03]
Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study. [2007.01]
Risk indexes for exacerbations and hospitalizations due to COPD. [2007.01]
[Treatment costs of otogenic vertigo] [2006.11.15]
Doxapram and aminophylline on bispectral index under sevoflurane anaesthesia: a comparative study. [2006.11]
The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients: adaptation of INNOVATE to Sweden. [2006.09]
Effect of obesity on clinical presentation and response to treatment in asthma. [2006.09]
Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function. [2006.08]
Urinary excretion of dietary contaminants in horses. [2006.08]
Aminophylline in bradyasystolic cardiac arrest: a randomised placebo-controlled trial. [2006.05.13]
Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients. [2006.05]
Bispectral index and regional cerebral oxygen saturation during propofol/N2O anesthesia. [2006.04]
Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma. [2006.03.02]
Aminophilline suppress the release of chemical mediators in treatment of acute asthma. [2006.03]
Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study. [2006.01]
Double-blind, randomised, controlled trial assessing controller medications in asthma. [2006]
Different bronchodilator combinations have similar effects on health status in COPD. [2006]
Impact of Chisan (ADAPT-232) on the quality-of-life and its efficacy as an adjuvant in the treatment of acute non-specific pneumonia. [2005.11]
[The additive effect of intravenous prednisolone for acute severe asthma in infants and toddlers: a randomized controlled clinical trial] [2005.10]
Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. [2005.09]
Reversal of oliguric tacrolimus nephrotoxicity in children. [2005.07]
Motion-sickness medications for aircrew: impact on psychomotor performance. [2005.06]
[Asthma control with the salmeterol-fluticasone-combination disc compared to standard treatment] [2005.03]
Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease? [2005.03]
Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m). [2005.03]
Effect of reproterol either alone or combined with disodium cromoglycate on airway responsiveness to methacholine. [2005]
Other research related to Elixophylline (Theophylline)
Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients. [2008.07]
[A 5-year-old boy with nonconvulsive status epilepticus induced by theophylline treatment] [2008.07]
A controlled porosity osmotic pump system with biphasic release of theophylline: influence of weight gain on its in vivo pharmacokinetics. [2008.06]
Comparison of gastroretentive microspheres and sustained-release preparations using theophylline pharmacokinetics. [2008.06]
[Clinical review of patients with seizures that developed during theophylline administration--(III) Safety of theophylline examined in patients who had sequelae or died] [2008.05]
Synthesis, pharmacological activity and nitric oxide generation by nitrate derivatives of theophylline. [2008.05]
Time-dependent effects of Klebsiella pneumoniae endotoxin (KPLPS) on the pharmacokinetics of theophylline in rats: return of the parameters in 96-hour KPLPS rats to the control levels. [2008.05]
Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: tablets and pellets. [2008.04]
[Population pharmacokinetic analysis of two theophylline formulations in premature neonates and infants with apnea] [2008.04]
Anti-inflammatory effect of theophylline in rats and its involvement of the glucocorticoid-glucocorticoid receptor system. [2008.04]
MK-0873, a PDE4 inhibitor, does not influence the pharmacokinetics of theophylline in healthy male volunteers. [2008.02.03]
[Case of an 81-year-old woman with theophylline-associated seizures followed by partial seizures due to vitamin B6 deficiency] [2008.02]
Theophylline-associated seizures and their clinical characterizations. [2008.02]
Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU. [2008.01]
Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline. [2008]
Effect of add-on therapy of tiotropium in COPD treated with theophylline. [2008]
MK-0873, a PDE4 inhibitor, does not influence the pharmacokinetics of theophylline in healthy male volunteers. [2008]
Influence of fumed silicon dioxide on the stabilization of Eudragit RS/RL 30 D film-coated theophylline pellets. [2008]
|
